TY - JOUR
T1 - An Azidoribose Probe to Track Ketoamine Adducts in Histone Ribose Glycation
AU - Maksimovic, Igor
AU - Maksimovic, Igor
AU - Zheng, Qingfei
AU - Trujillo, Marissa N.
AU - Galligan, James J.
AU - David, Yael
AU - David, Yael
AU - David, Yael
AU - David, Yael
N1 - Funding Information:
We thank Dr. Søren Heissel, Ph.D., Dr. Hanan Alwaseem, Ph.D., and Dr. Henrik Molina, Ph.D. of the Rockefeller Proteomics Resource Center for their invaluable assistance in LFQ data collection and analysis and Dr. George Sukenick and Rong Wang of the MSK Analytical Core Facility for expert NMR and mass spectral support. Work in the David lab is supported by the Josie Robertson Foundation, the Pershing Square Sohn Cancer Research Alliance, the NIH (CCSG core grant P30 CA008748, MSK SPORE P50 CA192937, and R21 DA044767), the Parker Institute for Cancer Immunotherapy (PICI), and the Anna Fuller Trust. In addition, the David lab is supported by Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research and the Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center. Elements of figures were prepared with BioRender.
Publisher Copyright:
Copyright © 2020 American Chemical Society.
PY - 2020/6/3
Y1 - 2020/6/3
N2 - Reactive cellular metabolites can modify macromolecules and form adducts known as nonenzymatic covalent modifications (NECMs). The dissection of the mechanisms, regulation, and consequences of NECMs, such as glycation, has been challenging due to the complex and often ambiguous nature of the adducts formed. Specific chemical tools are required to directly track the formation of these modifications on key targets in order to uncover their underlying physiological importance. Here, we present the novel chemoenzymatic synthesis of an active azido-modified ribose analog, 5-azidoribose (5-AR), as well as the synthesis of an inactive control derivative, 1-azidoribose (1-AR), and their application toward understanding protein ribose-glycation in vitro and in cellulo. With these new probes we found that, similar to methylglyoxal (MGO) glycation, ribose glycation specifically accumulates on histones. In addition to fluorescent labeling, we demonstrate the utility of the probe in enriching modified targets, which were identified by label-free quantitative proteomics and high-resolution MS/MS workflows. Finally, we establish that the known oncoprotein and hexose deglycase, fructosamine 3-kinase (FN3K), recognizes and facilitates the removal of 5-AR glycation adducts in live cells, supporting the dynamic regulation of ribose glycation as well as validating the probe as a new platform to monitor FN3K activity. Altogether, we demonstrate this probe's utilities to uncover ribose-glycation and deglycation events as well as track FN3K activity toward establishing its potential as a new cancer vulnerability.
AB - Reactive cellular metabolites can modify macromolecules and form adducts known as nonenzymatic covalent modifications (NECMs). The dissection of the mechanisms, regulation, and consequences of NECMs, such as glycation, has been challenging due to the complex and often ambiguous nature of the adducts formed. Specific chemical tools are required to directly track the formation of these modifications on key targets in order to uncover their underlying physiological importance. Here, we present the novel chemoenzymatic synthesis of an active azido-modified ribose analog, 5-azidoribose (5-AR), as well as the synthesis of an inactive control derivative, 1-azidoribose (1-AR), and their application toward understanding protein ribose-glycation in vitro and in cellulo. With these new probes we found that, similar to methylglyoxal (MGO) glycation, ribose glycation specifically accumulates on histones. In addition to fluorescent labeling, we demonstrate the utility of the probe in enriching modified targets, which were identified by label-free quantitative proteomics and high-resolution MS/MS workflows. Finally, we establish that the known oncoprotein and hexose deglycase, fructosamine 3-kinase (FN3K), recognizes and facilitates the removal of 5-AR glycation adducts in live cells, supporting the dynamic regulation of ribose glycation as well as validating the probe as a new platform to monitor FN3K activity. Altogether, we demonstrate this probe's utilities to uncover ribose-glycation and deglycation events as well as track FN3K activity toward establishing its potential as a new cancer vulnerability.
UR - http://www.scopus.com/inward/record.url?scp=85085854433&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085854433&partnerID=8YFLogxK
U2 - 10.1021/jacs.0c01325
DO - 10.1021/jacs.0c01325
M3 - Article
C2 - 32390412
AN - SCOPUS:85085854433
SN - 0002-7863
VL - 142
SP - 9999
EP - 10007
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 22
ER -